| Metric | შპს ჯი-ი-ეს-ეი ფარმაცევტიკალს | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾5.7m₾5.5m | ₾2.70bn₾2.32bn |
| Revenue growth | 2.4% | 16.6% |
| Profitability | ||
| EBITDA | ₾2.7m₾1.6m | — |
| EBITDA margin | 48.1%29.8% | — |
| Net profit | ₾2.6m₾1.6m | ₾1.84bn₾1.33bn |
| Net margin | 46.4%29.8% | 68.1%57.6% |
| Balance sheet | ||
| Total assets | ₾13.5m₾10.6m | ₾39.27bn₾31.39bn |
| Total equity | ₾11.7m₾9.1m | ₾5.63bn₾4.45bn |
| ROE | 22.4%18.1% | 32.6%30.0% |